CALR and myeloproliferative disorder: These findings indicate that the epitope of the mAb FMC 75 is accessible upon oligomerization, which is critical for some CRT functions [19], and that the epitope of FMC 75 could be a potential therapeutic target, e.g., in myeloproliferative diseases.